Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Implication of Angiography-Derived Index of Microcirculatory Resistance in Successfully Reperfused STEMI Patients

NCT04628377 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04628377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04628377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Implication of Angiography-Derived Index of Microcirculatory Resistance in Successfully Reperfused STEMI Patients
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
May 26, 2003
Completion date
April 1, 2023
Enrollment
333 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute st-segment elevation myocardial infarction